Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 13.85
+0.70 (5.32%)
Apr 20, 2026, 1:10 PM CST
Meribank Biotech Revenue
In the year 2025, Meribank Biotech had annual revenue of 471.76M TWD with 28.75% growth. Meribank Biotech had revenue of 250.42M in the half year ending June 30, 2025, with 142.98% growth.
Revenue
471.76M
Revenue Growth
+28.75%
P/S Ratio
2.73
Revenue / Employee
3.32M
Employees
142
Market Cap
1.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 471.76M | 105.33M | 28.75% |
| Dec 31, 2024 | 366.43M | 132.09M | 56.37% |
| Dec 31, 2023 | 234.34M | 54.22M | 30.10% |
| Dec 31, 2022 | 180.12M | 17.04M | 10.45% |
| Dec 31, 2021 | 163.08M | -31.32M | -16.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Level Biotechnology | 736.59M |
| Taiwan Advance Bio-Pharmaceutical | 371.86M |
| Abnova (Taiwan) | 351.30M |
| TCI GENE | 273.61M |
| NeoCore Technology | 244.66M |
| GeneReach Biotechnology | 232.74M |
| Lukas Biomedical | 180.32M |
| NatureWise Biotech & Medicals | 180.29M |